LENNAR CORP-A (LEN) Fundamental Analysis & Valuation

Name: LENNAR CORP-A (LEN) Fundamental Analysis Rating
Brand: LENNAR CORP-A

NYSE:LEN • US5260571048

89.45 USD

-0.8 (-0.89%)

Last: Mar 30, 2026, 12:35 PM

This LEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. LEN Profitability Analysis

1.1 Basic Checks

LEN had positive earnings in the past year.
LEN had a positive operating cash flow in the past year.
LEN had positive earnings in each of the past 5 years.
LEN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of LEN (5.98%) is better than 65.00% of its industry peers.
With a Return On Equity value of 9.37%, LEN perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
LEN has a Return On Invested Capital (6.47%) which is in line with its industry peers.
LEN had an Average Return On Invested Capital over the past 3 years of 9.80%. This is in line with the industry average of 9.21%.

		Industry Rank	Sector Rank
ROA	5.98%
ROE	9.37%
ROIC	6.47%

ROA(3y)8.44%

ROA(5y)10.1%

ROE(3y)12.66%

ROE(5y)15.59%

ROIC(3y)9.8%

ROIC(5y)11.6%

1.3 Margins

LEN's Profit Margin of 6.02% is fine compared to the rest of the industry. LEN outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of LEN has declined.
LEN has a Operating Margin (8.09%) which is comparable to the rest of the industry.
LEN's Operating Margin has declined in the last couple of years.
LEN's Gross Margin of 10.38% is on the low side compared to the rest of the industry. LEN is outperformed by 95.00% of its industry peers.
In the last couple of years the Gross Margin of LEN has declined.

		Industry Rank	Sector Rank
OM	8.09%
PM (TTM)	6.02%
GM	10.38%

OM growth 3Y-27%

OM growth 5Y-11.92%

PM growth 3Y-23.69%

PM growth 5Y-11.09%

GM growth 3Y-20.86%

GM growth 5Y-8.29%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. LEN Health Analysis

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN is creating some value.
The number of shares outstanding for LEN has been reduced compared to 1 year ago.
LEN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LEN is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.77 indicates that LEN is not in any danger for bankruptcy at the moment.
The Altman-Z score of LEN (3.77) is better than 66.67% of its industry peers.
LEN has a debt to FCF ratio of 208.46. This is a negative value and a sign of low solvency as LEN would need 208.46 years to pay back of all of its debts.
With a Debt to FCF ratio value of 208.46, LEN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.27 indicates that LEN is not too dependend on debt financing.
LEN has a Debt to Equity ratio (0.27) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	208.46
Altman-Z	3.77

ROIC/WACC0.74

WACC8.76%

2.3 Liquidity

LEN has a Current Ratio of 8.22. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.22, LEN belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
A Quick Ratio of 2.52 indicates that LEN has no problem at all paying its short term obligations.
LEN's Quick ratio of 2.52 is amongst the best of the industry. LEN outperforms 88.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.22
Quick Ratio	2.52

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. LEN Growth Analysis

3.1 Past

LEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.31%.
Measured over the past 5 years, LEN shows a small growth in Earnings Per Share. The EPS has been growing by 0.33% on average per year.
The Revenue has decreased by -3.54% in the past year.
The Revenue has been growing by 8.74% on average over the past years. This is quite good.

EPS 1Y (TTM)-49.31%

EPS 3Y-20.53%

EPS 5Y0.33%

EPS Q2Q%-52.55%

Revenue 1Y (TTM)-3.54%

Revenue growth 3Y0.51%

Revenue growth 5Y8.74%

Sales Q2Q%-13.26%

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, LEN will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.

EPS Next Y-15.56%

EPS Next 2Y2.33%

EPS Next 3Y10.78%

EPS Next 5Y25.99%

Revenue Next Year-2.45%

Revenue Next 2Y0.88%

Revenue Next 3Y3.93%

Revenue Next 5Y7.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks Show best growing peers

4. LEN Valuation Analysis

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.85, LEN is valued correctly.
LEN's Price/Earnings is on the same level as the industry average.
LEN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.89.
With a Price/Forward Earnings ratio of 10.69, the valuation of LEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LEN is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, LEN is valued rather cheaply.

		Industry Rank	Sector Rank
PE	12.85
Fwd PE	10.69

4.2 Price Multiples

LEN's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LEN indicates a slightly more expensive valuation: LEN is more expensive than 68.33% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	785.92
EV/EBITDA	8.43

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)39.11

EPS Next 2Y2.33%

EPS Next 3Y10.78%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. LEN Dividend Analysis

5.1 Amount

LEN has a Yearly Dividend Yield of 2.20%.
Compared to an average industry Dividend Yield of 1.31, LEN pays a bit more dividend than its industry peers.
LEN's Dividend Yield is comparable with the S&P500 average which is at 1.89.

		Industry Rank	Sector Rank
Dividend Yield	2.2%

5.2 History

On average, the dividend of LEN grows each year by 26.65%, which is quite nice.
LEN has paid a dividend for at least 10 years, which is a reliable track record.
LEN has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)26.65%

Div Incr Years1

Div Non Decr Years15

5.3 Sustainability

LEN pays out 25.31% of its income as dividend. This is a sustainable payout ratio.
LEN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.

DP25.31%

EPS Next 2Y2.33%

EPS Next 3Y10.78%

More info and screens

Find the best dividend stocks Show peers with best dividend

LEN Fundamentals: All Metrics, Ratios and Statistics

LENNAR CORP-A

NYSE:LEN (3/30/2026, 12:35:09 PM)

89.45

-0.8 (-0.89%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)03-12 2026-03-12/amc

Earnings (Next)06-15 2026-06-15/amc

Inst Owners93.57%

Inst Owner Change-2.98%

Ins Owners0.29%

Ins Owner Change1.59%

Market Cap22.15B

Revenue(TTM)34.19B

Net Income(TTM)2.06B

Analysts53.08

Price Target102.16 (14.21%)

Short Float %4.55%

Short Ratio3.11

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.2%

Yearly Dividend2.02

Dividend Growth(5Y)26.65%

DP25.31%

Div Incr Years1

Div Non Decr Years15

Ex-Date02-04 2026-02-04 (0.5)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-2.91%

Min EPS beat(2)-13.73%

Max EPS beat(2)7.91%

EPS beat(4)2

Avg EPS beat(4)-0.42%

Min EPS beat(4)-13.73%

Max EPS beat(4)11.86%

EPS beat(8)5

Avg EPS beat(8)4.01%

EPS beat(12)9

Avg EPS beat(12)8.75%

EPS beat(16)11

Avg EPS beat(16)4.95%

Revenue beat(2)1

Avg Revenue beat(2)-0.1%

Min Revenue beat(2)-3.05%

Max Revenue beat(2)2.85%

Revenue beat(4)3

Avg Revenue beat(4)0.78%

Min Revenue beat(4)-3.05%

Max Revenue beat(4)2.85%

Revenue beat(8)5

Avg Revenue beat(8)0.29%

Revenue beat(12)9

Avg Revenue beat(12)2.51%

Revenue beat(16)11

Avg Revenue beat(16)1.94%

PT rev (1m)-8.07%

PT rev (3m)-13.65%

EPS NQ rev (1m)-0.64%

EPS NQ rev (3m)-0.89%

EPS NY rev (1m)-2.06%

EPS NY rev (3m)-12.14%

Revenue NQ rev (1m)-0.07%

Revenue NQ rev (3m)-0.29%

Revenue NY rev (1m)-0.78%

Revenue NY rev (3m)-2.86%

Valuation

		Industry Rank	Sector Rank
PE	12.85
Fwd PE	10.69
P/S	0.65
P/FCF	785.92
P/OCF	102.16
P/B	1.01
P/tB	1.21
EV/EBITDA	8.43

EPS(TTM)6.96

EY7.78%

EPS(NY)8.37

Fwd EY9.35%

FCF(TTM)0.11

FCFY0.13%

OCF(TTM)0.88

OCFY0.98%

SpS138.06

BVpS88.68

TBVpS74.01

PEG (NY)N/A

PEG (5Y)39.11

Graham Number117.85

Profitability

		Industry Rank	Sector Rank
ROA	5.98%
ROE	9.37%
ROCE	8.55%
ROIC	6.47%
ROICexc	7.33%
ROICexgc	12.52%
OM	8.09%
PM (TTM)	6.02%
GM	10.38%
FCFM	0.08%

ROA(3y)8.44%

ROA(5y)10.1%

ROE(3y)12.66%

ROE(5y)15.59%

ROIC(3y)9.8%

ROIC(5y)11.6%

ROICexc(3y)11.54%

ROICexc(5y)13.41%

ROICexgc(3y)16.37%

ROICexgc(5y)17.4%

ROCE(3y)12.94%

ROCE(5y)15.31%

ROICexgc growth 3Y-14.19%

ROICexgc growth 5Y2.33%

ROICexc growth 3Y-24.42%

ROICexc growth 5Y-4.96%

OM growth 3Y-27%

OM growth 5Y-11.92%

PM growth 3Y-23.69%

PM growth 5Y-11.09%

GM growth 3Y-20.86%

GM growth 5Y-8.29%

F-Score5

Asset Turnover0.99

Health

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	208.46
Debt/EBITDA	2.03
Cap/Depr	140.44%
Cap/Sales	0.55%
Interest Coverage	55.18
Cash Conversion	7.47%
Profit Quality	1.37%
Current Ratio	8.22
Quick Ratio	2.52
Altman-Z	3.77

F-Score5

WACC8.76%

ROIC/WACC0.74

Cap/Depr(3y)126.5%

Cap/Depr(5y)104.2%

Cap/Sales(3y)0.44%

Cap/Sales(5y)0.35%

Profit Quality(3y)63.09%

Profit Quality(5y)63.2%

High Growth Momentum

Growth

EPS 1Y (TTM)-49.31%

EPS 3Y-20.53%

EPS 5Y0.33%

EPS Q2Q%-52.55%

EPS Next Y-15.56%

EPS Next 2Y2.33%

EPS Next 3Y10.78%

EPS Next 5Y25.99%

Revenue 1Y (TTM)-3.54%

Revenue growth 3Y0.51%

Revenue growth 5Y8.74%

Sales Q2Q%-13.26%

Revenue Next Year-2.45%

Revenue Next 2Y0.88%

Revenue Next 3Y3.93%

Revenue Next 5Y7.26%

EBIT growth 1Y-46.35%

EBIT growth 3Y-26.63%

EBIT growth 5Y-4.23%

EBIT Next Year-17.49%

EBIT Next 3Y10.01%

EBIT Next 5Y18.06%

FCF growth 1Y-98.74%

FCF growth 3Y-79.37%

FCF growth 5Y-63.1%

OCF growth 1Y-90.98%

OCF growth 3Y-59.51%

OCF growth 5Y-44.7%

LENNAR CORP-A / LEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LENNAR CORP-A (LEN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.

What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 3 / 10 to LENNAR CORP-A (LEN). This can be considered as Overvalued.

How profitable is LENNAR CORP-A (LEN) stock?

LENNAR CORP-A (LEN) has a profitability rating of 4 / 10.

How financially healthy is LENNAR CORP-A?

The financial health rating of LENNAR CORP-A (LEN) is 6 / 10.

Is the dividend of LENNAR CORP-A sustainable?

The dividend rating of LENNAR CORP-A (LEN) is 6 / 10 and the dividend payout ratio is 25.31%.